JP2013527756A - 電気的に伝導される高周波電流の皮膚への投与に関連する、遺伝子シグネチャー及び遺伝子チップ、並びにそれらに関連する方法及び処置 - Google Patents

電気的に伝導される高周波電流の皮膚への投与に関連する、遺伝子シグネチャー及び遺伝子チップ、並びにそれらに関連する方法及び処置 Download PDF

Info

Publication number
JP2013527756A
JP2013527756A JP2013506231A JP2013506231A JP2013527756A JP 2013527756 A JP2013527756 A JP 2013527756A JP 2013506231 A JP2013506231 A JP 2013506231A JP 2013506231 A JP2013506231 A JP 2013506231A JP 2013527756 A JP2013527756 A JP 2013527756A
Authority
JP
Japan
Prior art keywords
skin
gene
treatment
high frequency
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013506231A
Other languages
English (en)
Japanese (ja)
Inventor
ジョン ヴァイスゲルバー デービッド
エリザベス アンヌンツィアータ ニッキ
ジャニーン マウラー ティア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JP2013527756A publication Critical patent/JP2013527756A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
JP2013506231A 2010-04-19 2011-04-19 電気的に伝導される高周波電流の皮膚への投与に関連する、遺伝子シグネチャー及び遺伝子チップ、並びにそれらに関連する方法及び処置 Pending JP2013527756A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32563310P 2010-04-19 2010-04-19
US61/325,633 2010-04-19
PCT/US2011/033033 WO2011133538A1 (en) 2010-04-19 2011-04-19 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto

Publications (1)

Publication Number Publication Date
JP2013527756A true JP2013527756A (ja) 2013-07-04

Family

ID=44343224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013506231A Pending JP2013527756A (ja) 2010-04-19 2011-04-19 電気的に伝導される高周波電流の皮膚への投与に関連する、遺伝子シグネチャー及び遺伝子チップ、並びにそれらに関連する方法及び処置

Country Status (8)

Country Link
EP (1) EP2561092A1 (pt)
JP (1) JP2013527756A (pt)
KR (1) KR20120137407A (pt)
CN (1) CN102869789B (pt)
BR (1) BR112012026870A2 (pt)
CA (1) CA2795671A1 (pt)
MX (1) MX2012012235A (pt)
WO (1) WO2011133538A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9671410B2 (en) 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
EP2691539B1 (en) 2011-03-31 2018-04-25 The Procter and Gamble Company Methods for identifying and evaluating skin-active agents effective for treating dandruff
US10418127B2 (en) * 2012-03-30 2019-09-17 The Procter & Gamble Company Method of formulating a skin-lightening composition
EP2859486A2 (en) 2012-06-06 2015-04-15 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
EP2885423B1 (en) 2012-08-15 2017-09-27 The Procter and Gamble Company Systems for identifying and evaluating skin-active agents effective for treating an array of skin disorders
WO2016077327A1 (en) 2014-11-10 2016-05-19 The Procter & Gamble Company Personal care compositions with two benefit phases
CN107106429B (zh) 2014-11-10 2021-06-29 宝洁公司 具有两种有益相的个人护理组合物
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
WO2019079409A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company CLEANER FOR AEROSOL MOUSSE FOAM
WO2019079405A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company AEROSOL FOAMING CLEANSER FOR THE SKIN
CN113015904A (zh) 2018-11-29 2021-06-22 宝洁公司 用于筛选个人护理产品的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128641A1 (en) * 1999-08-30 2002-09-12 Arthrocare Corporation Systems and methods for intradermal collagen stimulation

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0430881A3 (en) 1989-11-29 1991-10-23 Ciba-Geigy Ag Photochromic compounds, process for their preparation and their use
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
US5366443A (en) 1992-01-07 1994-11-22 Thapliyal And Eggers Partners Method and apparatus for advancing catheters through occluded body lumens
EP0636186B1 (en) 1992-04-03 1998-11-25 The Perkin-Elmer Corporation Probe composition and method
US5503980A (en) 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5470710A (en) 1993-10-22 1995-11-28 University Of Utah Automated hybridization/imaging device for fluorescent multiplex DNA sequencing
GB9401833D0 (en) 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
GB9507238D0 (en) 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US5660836A (en) 1995-05-05 1997-08-26 Knowlton; Edward W. Method and apparatus for controlled contraction of collagen tissue
US6430446B1 (en) 1995-05-05 2002-08-06 Thermage, Inc. Apparatus for tissue remodeling
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US5661028A (en) 1995-09-29 1997-08-26 Lockheed Martin Energy Systems, Inc. Large scale DNA microsequencing device
US6228078B1 (en) 1995-11-22 2001-05-08 Arthrocare Corporation Methods for electrosurgical dermatological treatment
US6350276B1 (en) 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
ATE298536T1 (de) 1999-03-09 2005-07-15 Thermage Inc Vorichtung zur behandlung von gewebe
US6702808B1 (en) 2000-09-28 2004-03-09 Syneron Medical Ltd. Device and method for treating skin
WO2002032332A1 (en) * 2000-10-18 2002-04-25 Mattoli Engineering Ltd. Method and apparatus for plasma skin resurfacing
US6889090B2 (en) 2001-11-20 2005-05-03 Syneron Medical Ltd. System and method for skin treatment using electrical current
US6662054B2 (en) 2002-03-26 2003-12-09 Syneron Medical Ltd. Method and system for treating skin
EP1558339A1 (en) 2002-10-07 2005-08-03 Palomar Medical Technologies, Inc. Apparatus for performing photobiostimulation
US7643883B2 (en) * 2005-01-28 2010-01-05 Syneron Medical Ltd. Device and method for treating skin
SI22738A (sl) * 2008-04-11 2009-10-31 Iskra Medical, D.O.O. Naprava za radiofrekvenčno krožno globinsko terapijo

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128641A1 (en) * 1999-08-30 2002-09-12 Arthrocare Corporation Systems and methods for intradermal collagen stimulation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN5013009157; 'ＡＦＦＹＭＥＴＲＩＸ　ＧＥＮＥＣＨＩＰ　ＨＵＭＡＮ　ＧＥＮＯＭＥ　Ｕ１３３　ＰＬＵＳ　２．０　ＡＲＲＡＹ' ＧＥＯ , 20031107 *
JPN6014005893; Ｊ．　Ａｍ．　Ａｃａｄ．　Ｄｅｒｍａｔｏｌ．，　（２００９），　６０，　［３］，　ｐ．ＡＢ１（Ｐ１００） *

Also Published As

Publication number Publication date
WO2011133538A1 (en) 2011-10-27
BR112012026870A2 (pt) 2017-01-10
MX2012012235A (es) 2012-11-23
KR20120137407A (ko) 2012-12-20
CN102869789B (zh) 2015-09-30
CN102869789A (zh) 2013-01-09
EP2561092A1 (en) 2013-02-27
CA2795671A1 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
JP2013527756A (ja) 電気的に伝導される高周波電流の皮膚への投与に関連する、遺伝子シグネチャー及び遺伝子チップ、並びにそれらに関連する方法及び処置
Weiss Noninvasive radio frequency for skin tightening and body contouring
Sadick et al. Selective electro‐thermolysis in aesthetic medicine: A review
JP4739202B2 (ja) 熱傷、創傷、および関連皮膚疾患の光力学治療のためのシステムおよび方法
US20050283211A1 (en) Photomodulation methods and devices for regulating cell proliferation and gene expression
Beigvand et al. Assessment of laser effects on skin rejuvenation
Taub et al. Treatment of acne scars of skin types II to V by sublative fractional bipolar radiofrequency and bipolar radiofrequency combined with diode laser
Loesch et al. Skin resurfacing procedures: new and emerging options
El‐Domyati et al. Expression of transforming growth factor‐β after different non‐invasive facial rejuvenation modalities
Akita et al. The clinical experience and efficacy of bipolar radiofrequency with fractional photothermolysis for aged A sian skin
Fiório et al. Effect of incoherent LED radiation on third-degree burning wounds in rats
Kim et al. Gene profiling analysis of the early effects of ablative fractional carbon dioxide laser treatment on human skin
JP2013524946A (ja) 哺乳類の皮膚の状態を調節するための、エネルギー及び局所適用組成物の併用
Goel et al. Use of nanofractional radiofrequency for the treatment of acne scars in Indian skin
US20120271219A1 (en) Combined Energy and Topical Composition Application For Regulating the Condition of Mammalian Skin
Luo et al. Impact of intense pulse light irradiation on BALB/c mouse skin—in vivo study on collagens, matrix metalloproteinases and vascular endothelial growth factor
Chan et al. An animal study of the effects on p16 and PCNA expression of repeated treatment with high‐energy laser and intense pulsed light exposure
Trelles et al. Adipocyte membrane lysis observed after cellulite treatment is performed with radiofrequency
US20120270743A1 (en) Genetic Signatures and Gene Chips Associated With Administration of Electrically Conducted Radio Frequency Current to Skin and Methods and Treatments Relating Thereto
Levenberg et al. Treatment of wrinkles and acne scars using the TriFractional, a novel fractional radiofrequency technology—clinical and histological results
US20100081185A1 (en) System and method for photodynamic cell therapy
Boisnic et al. Ex vivo study of the home-use TriPollar RF device using an experimental human skin model
Meghe et al. Shedding Light on Acne Scars: A Comprehensive Review of CO2 vs. Erbium-Doped Yttrium Aluminium Garnet (Er: YAG) Laser Therapy
Dantas et al. Ethnicity and Dermatology
Kavita Beri Neocollagenesis in Deep and Superficial Dermis by Combining Fractionated Q-Switched ND: YAG 1,064-nm With Topical Plant Stem Cell Extract and N-Acetyl Glucosamine: Open Case Series

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140110

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140507

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150303

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150623